September 9, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug JENTADUETO Posted in: Uncategorized
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post Patent delisted for Boehringer Ingelheim drug JENTADU…
September 9, 2020 Comments Off on Patent delisted for Acorda drug AMPYRA Posted in: Uncategorized
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
